Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-09

Clinical Trial Update: HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing HDR brachytherapy to LDR brachytherapy as monotherapy for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED